At ImpriMed, we are passionate about bringing you accurate information to help you optimize your patient's treatment outcomes. We are thrilled to announce that our Multidrug Sensitivity Genotyping (MDR1) is now available to provide you actionable information about the sensitivity of your canine patients to many commonly-used drugs. Detection of MDR1 mutations is particularly important for preventing adverse events in breeds such as Collies, Long-haired Whippets, and Australian Shepherds, but any breed may harbor these mutations. By testing for MDR1 mutations, you can be proactive in avoiding potential adverse reactions and ensuring the safety and well-being of your patients.
Our Multidrug Sensitivity Genotyping (MDR1) is exclusively available to veterinary teams. By offering this service add-on to our other services, we make it easy for you to get comprehensive cancer profiling information with one simple order. This means faster turnaround times and a more streamlined process for your clients.
If MDR1 genotyping is added to other services:
For standalone MDR1 genotyping requests:
If MDR1 genotyping is added to other services:
For standalone MDR1 genotyping requests:
You can order ImpriMed's Multidrug Sensitivity Genotyping (MDR1) through our Vet Portal.
We're committed to providing you with the best possible experience, and we're confident that our Multidrug Sensitivity Genotyping (MDR1) will help you make informed treatment decisions for your patients. Request pricing by emailing us at support@imprimedicine.com. If you have any other questions or would like to learn more about our other services, please don't hesitate to reach out to us.
Thank you for choosing ImpriMed as your partner in personalized pet cancer care.